News & Perspective

Dec 17, 2012

Dec 17, 2012

With more surveillance, flu patterns in Africa begin to emerge

(CIDRAP News) – Increased surveillance in recent years has begun to fill in some of the huge information gaps regarding influenza in Africa, which should eventually make it possible to develop or improve public health interventions, according to a big collection of articles published recently in the Journal of Infectious Diseases (JID).

Oct 30, 2012

Oct 30, 2012

CDC profiles wide range of global flu activities

(CIDRAP News) – An annual report released yesterday by the US Centers for Disease Control and Prevention (CDC) profiles a wide range of CDC influenza-related projects around the world, from flu surveillance in Indonesia to vaccine effectiveness studies in El Salvador and epidemiology training in Ghana.

Jul 12, 2010

Jul 12, 2010

ICEID COVERAGE Experts air H1N1 lessons, other disease challenges

– ATLANTA (CIDRAP News) – The vital role of preparedness, from diagnostic testing to stockpiling of antiviral medications, was one of the most important lessons from assessments of the world's response to the H1N1 influenza pandemic, the World Health Organization's (WHO's) top flu expert told an international infectious diseases conference yesterday.

Jun 25, 2009

Jun 25, 2009

Pandemic reveals strengths of new flu database

(CIDRAP News) – Against the backdrop of a global struggle to solve a dispute related to H5N1 avian influenza virus sharing and an anxious watch over the novel H1N1 virus sweeping the globe, a new public database for sharing influenza genetic sequences is easing the flow of data and winning the support of a growing community of researchers and health officials, even some from countries that have sparred in the past over intellectual property rights.

Jun 23, 2008

Jun 23, 2008

Health leaders: World far from ready for flu pandemic

(CIDRAP News) – The world is far from being well prepared for an influenza pandemic, leading national and international health officials warned at a meeting in Malaysia last week.

As the H5N1 avian influenza virus continues to thrive in birds, there is no vaccine that can provide sure protection if it evolves into a pandemic strain, and governments are paying less attention to the threat, officials said.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 25, 2007

Oct 25, 2007

THE PANDEMIC VACCINE PUZZLE Part 1: Flu research: a legacy of neglect

Editor's note: This is the first in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Aug 23, 2006

Aug 23, 2006

CDC begins sharing flu virus genetic data

(CIDRAP News) – The Centers for Disease Control and Prevention (CDC) has published the genetic blueprints for more than 650 influenza virus genes to launch a new data-sharing program intended to stimulate influenza research.

Mar 16, 2006

Mar 16, 2006

Roche boosts Tamiflu production; CDC cites signs of hoarding

(CIDRAP News) – Drug manufacturer Roche said today it is increasing its production capacity for the antiviral drug oseltamivir (Tamiflu) by a third this year and is keeping ahead of the demand from governments stockpiling the drug in preparation for a possible influenza pandemic.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»